- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Cancer Genome Atlas ; volume:42 ; number:04 ; year:2021 ; pages:353-355
Indian journal of medical & paediatric oncology ; 42, Heft 04 (2021), 353-355
- Beteiligte Personen und Organisationen
-
Muddabhaktuni, B. Minu Chandra
Koyyala, Venkata Pradeep Babu
- DOI
-
10.1055/s-0041-1735440
- URN
-
urn:nbn:de:101:1-2022031911051538406046
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Muddabhaktuni, B. Minu Chandra
- Koyyala, Venkata Pradeep Babu
Ähnliche Objekte (12)
Building a translational cancer dependency map for The Cancer Genome Atlas
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas
Global mapping of cancers : The Cancer Genome Atlas and beyond
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data
Comparing variants related to chronic diseases from genome-wide association study (GWAS) and the cancer genome atlas (TCGA)
Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer
The Roche Cancer Genome Database 2.0
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients
Building a translational cancer dependency map for The Cancer Genome Atlas
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas
Global mapping of cancers : The Cancer Genome Atlas and beyond
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data
Comparing variants related to chronic diseases from genome-wide association study (GWAS) and the cancer genome atlas (TCGA)
Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer
The Roche Cancer Genome Database 2.0
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE
A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients
Building a translational cancer dependency map for The Cancer Genome Atlas
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas
Global mapping of cancers : The Cancer Genome Atlas and beyond
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data
Comparing variants related to chronic diseases from genome-wide association study (GWAS) and the cancer genome atlas (TCGA)
Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer
The Roche Cancer Genome Database 2.0
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE